Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

CD83 (RPCAR01) CAR T in Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase I Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06871410
Title field or adapter rule
{'original_value': 'CD83 (RPCAR01) CAR T in Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase I Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-11-01T01:03:13.192891+00:00
Published At
2026-10-27T00:00:00+00:00
Record Updated At
2026-10-27
Source Retrieved At
2026-11-01T01:03:12.230707+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-27", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06871410"
protocolSection.identificationModule.officialTitle
"CD83 (RPCAR01) CAR T in Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase I Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Recurrent Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Given IV', 'name': 'Autologous Anti-CD83 CAR T-cells', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo bone marrow aspiration blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo chest x-ray', 'name': 'Chest Radiography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Given IV', 'name': 'Cyclophosphamide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo ECHO', 'name': 'Echocardiography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Given IV', 'name': 'Fludarabine Phosphate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Given hydroxyurea', 'name': 'Hydroxyurea', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo leukapheresis', 'name': 'Leukapheresis', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo lumbar puncture', 'name': 'Lumbar Puncture', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Undergo PET', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (fludarabine, cyclophosphamide, CD83 CAR T-cells)'], 'description': 'Ancillary studies', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Autologous Anti-CD83 CAR T-cells (protocolSection.armsInterventionsModule.interventions[].name)
  • Cyclophosphamide (protocolSection.armsInterventionsModule.interventions[].name)
  • Fludarabine Phosphate (protocolSection.armsInterventionsModule.interventions[].name)
  • Hydroxyurea (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.